$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$2.09B
Market Cap
28.36
P/E Ratio
0.56
EPS
$16.48
52 Week High
$6.55
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Aurinia Pharmaceuticals Inc. (AUPH) is a biopharmaceutical company dedicated to developing innovative therapies for serious diseases, with a primary focus on lupus nephritis. Based in Victoria, Canada, the company utilizes its extensive drug development expertise to create and deliver impactful treatment solutions, targeting critical healthcare needs in major markets including Japan and China. Aurinia's commitment to enhancing patient outcomes positions it strategically in the evolving biopharmaceutical sector, with ongoing potential for growth as it addresses significant unmet medical needs.
LPTX
KIND
NVDA
WOK
F
KAVL
ADAP
CGC
TLRY
TSLA
AVGO
NIO
PFE
PLTD
ASST
CDE
SNAP
MTSR
FI
APLT
HBAN
CCL
UBER
KO
WULF
SOUN
CAN
EOSE
INTC
MSTR
MU
CX
ASBP
RR
ITUB
PLUG
MDLZ
NVTS
TSM
CLSK
CPNG
SHOT
ZAPP
RXRX
VALE
IVP
HL
ORCL
NBIS
PG
SPR
KMI
C
HOOD
PLTR
CVE
HPQ
HIMS
USB
CSX
LULU
FITB
HST
GM
LPTX
KIND
NVDA
WOK
F
KAVL
ADAP
CGC
TLRY
TSLA
AVGO
NIO
PFE
PLTD
ASST
CDE
SNAP
MTSR
FI
APLT
HBAN
CCL
UBER
KO
WULF
SOUN
CAN
EOSE
INTC
MSTR
MU
CX
ASBP
RR
ITUB
PLUG
MDLZ
NVTS
TSM
CLSK
CPNG
SHOT
ZAPP
RXRX
VALE
IVP
HL
ORCL
NBIS
PG
SPR
KMI
C
HOOD
PLTR
CVE
HPQ
HIMS
USB
CSX
LULU
FITB
HST
GM